» Articles » PMID: 34095666

Multi-epitope-Based Vaccine Designed by Targeting Cytoadherence Proteins of

Overview
Journal ACS Omega
Specialty Chemistry
Date 2021 Jun 7
PMID 34095666
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

causes chronic respiratory disease in chickens leading to large economic losses in the poultry industry, and the impacts remain to be a great challenge for a longer period. Among the other approaches, a vaccine targeting the adhesion proteins of would be a promising candidate in controlling the infection. Thus, the present study is aimed to design a multi-epitope vaccine candidate using cytoadhesion proteins of through an advanced immunoinformatics approach. As a result, the multi-epitope vaccine was constructed, which comprised potential T-cell and B-cell binding epitopes with appropriate adjuvants. The designed multi-epitope vaccine represented high antigenicity with viable physiochemical properties. The prospective three-dimensional structure of the epitope was predicted, refined, and validated. The molecular docking analysis of multi-epitope vaccine candidates with the chicken Toll-like receptor-5 predicted effective binding. Furthermore, codon optimization and in silico cloning ensured high expression. Thus, the present finding indicates that the engineered multi-epitope vaccine is structurally stable and can induce a strong immune response. Furthermore, the multi-epitope vaccine is suggested to be a suitable vaccine candidate for the infection due to its effective binding capacity and precise specificity.

Citing Articles

Designing a multi-epitope vaccine candidate against human rhinovirus C utilizing immunoinformatics approach.

Mamun T, Ali M, Hosen M, Rahman J, Islam M, Akib M Front Immunol. 2025; 15():1364129.

PMID: 39840071 PMC: 11747413. DOI: 10.3389/fimmu.2024.1364129.


Immunoinformatics Design of a Multiepitope Vaccine (MEV) Targeting : A Novel Computational Approach.

Naorem R, Pangabam B, Bora S, Fekete C, Teli A Pathogens. 2024; 13(10).

PMID: 39452787 PMC: 11509883. DOI: 10.3390/pathogens13100916.


Research Progress in the Development of Vaccines against Mycoplasma and Mycoplasma .

Wu S, Wang M, Yang X, Zhao L, Lan Z, Sun S Microorganisms. 2024; 12(8).

PMID: 39203540 PMC: 11356929. DOI: 10.3390/microorganisms12081699.


Designing and development of efficient multi-epitope-based peptide vaccine candidate against emerging avian rotavirus strains: A vaccinomic approach.

Hasan M, Ahmed S, Imranuzzaman M, Bari R, Roy S, Hasan M J Genet Eng Biotechnol. 2024; 22(3):100398.

PMID: 39179326 PMC: 11260576. DOI: 10.1016/j.jgeb.2024.100398.


Universal peptide-based potential vaccine design against canine distemper virus (CDV) using a vaccinomic approach.

Rendon-Marin S, Ruiz-Saenz J Sci Rep. 2024; 14(1):16605.

PMID: 39026076 PMC: 11258135. DOI: 10.1038/s41598-024-67781-5.


References
1.
Vance A, Branton S, Collier S, Gerard P, Peebles E . Effects of time-specific F-strain Mycoplasma gallisepticum inoculation overlays on prelay ts11-strain Mycoplasma gallisepticum inoculation on performance characteristics of commercial laying hens. Poult Sci. 2008; 87(4):655-60. DOI: 10.3382/ps.2007-00492. View

2.
Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y . The I-TASSER Suite: protein structure and function prediction. Nat Methods. 2014; 12(1):7-8. PMC: 4428668. DOI: 10.1038/nmeth.3213. View

3.
Kar T, Narsaria U, Basak S, Deb D, Castiglione F, Mueller D . A candidate multi-epitope vaccine against SARS-CoV-2. Sci Rep. 2020; 10(1):10895. PMC: 7331818. DOI: 10.1038/s41598-020-67749-1. View

4.
El Gazzar M, Laibinis V, Ferguson-Noel N . Characterization of a ts-1-like Mycoplasma galisepticum isolate from commercial broiler chickens. Avian Dis. 2012; 55(4):569-74. DOI: 10.1637/9689-021711-Reg.1. View

5.
Hala K, Boyd R, Wick G . Chicken major histocompatibility complex and disease. Scand J Immunol. 1981; 14(6):607-16. DOI: 10.1111/j.1365-3083.1981.tb00602.x. View